March 31, 2025IR
News
February 6, 2025IR
Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2024 [IFRS][Teijin]
February 6, 2025IR
Flash Report -Results of FY2024 3Q & Outlook for FY2024-[Teijin]
February 3, 2025IR
Notice Regarding Transition to a Company with an Audit & Supervisory Committee[Teijin] (PDF: 124.5 KB)
January 10, 2025IR
Notice Concerning Change of Major Shareholder[Teijin] (PDF: 86.1 KB)
December 19, 2024IR
Notice on Change in an Equity Method Affiliated Company (Share Transfer)[Teijin] (PDF: 158.8 KB)
November 7, 2024IR
Summary of Consolidated Financial Results for the Six Months Ended September 30, 2024 [IFRS][Teijin]
November 7, 2024IR
Flash Report -Results of FY2024 2Q & Outlook for FY2024-[Teijin]
November 7, 2024IR
Notice regarding Revision of Full-Year Earnings Forecasts, Recording of Impairment Losses (consolidated) and Extraordinary Loss (individual), Payment of Interim Dividend, and Forecast of Year-End Dividend[Teijin] (PDF: 238.0 KB)
August 6, 2024IR
Summary of Consolidated Financial Results for the Three Months Ended June 30, 2024 [IFRS][Teijin]
August 6, 2024IR
Flash Report -Results of FY2024 1Q & Outlook for FY2024-[Teijin]
July 17, 2024IR
Notice Concerning Completion of Payment for the Disposal of Treasury Shares as “Restricted Stock”[Teijin] (PDF: 116.0 KB)
June 20, 2024IR
Notice Concerning the Disposal of Treasury Shares as “Restricted Stock”[Teijin] (PDF: 150.1 KB)
June 18, 2024CorporateIR
Notice of Change in a Consolidated Subsidiary (Share Transfer) and Revision of Financial Forecasts[Teijin] (PDF: 130.6 KB)
June 18, 2024CorporateIR
Notice Regarding Media Articles[Teijin] (PDF: 305.8 KB)
June 3, 2024CorporateIR
Notice Regarding Media Articles[Teijin] (PDF: 109.3 KB)
May 22, 2024IR
Notice Regarding Change in Representative Directors[Teijin] (PDF: 143.2 KB)
May 13, 2024IR
Teijin Group Medium-Term Management Plan 2024-2025[Teijin]
May 13, 2024IR
Consolidated Financial Statements Summary (For the year ended March 31, 2024)[Teijin]
May 13, 2024IR
Flash Report -Results of FY2023 & Outlook for FY2024-[Teijin]
May 13, 2024IR
Notice Regarding Differences between the FY2023 Financial Forecast and the Actual Results[Teijin] (PDF: 110.7 KB)
May 13, 2024IR
Notice Concerning Revision of Restricted Stock Remuneration Plan and Performance-linked Stock Remuneration Plan for Directors of the Company[Teijin] (PDF: 132.1 KB)
February 8, 2024IR
Consolidated Financial Statements Summary (For the nine months ended December 31, 2023)[Teijin]
February 8, 2024IR
Flash Report -Results of FY2023 3Q & Outlook for FY2023-[Teijin]
February 8, 2024IR
Notice Regarding the Revision of Financial Forecasts[Teijin] (PDF: 151.9 KB)
February 8, 2024IR
Notice Regarding the Recording of Insurance Income[Teijin] (PDF: 138.9 KB)
February 8, 2024IR
Notice Regarding Recording of Non-operating Income (Equity in Earnings of Affiliates) due to Partial Resolution of Litigation Involving an Unconsolidated Subsidiary[Teijin] (PDF: 147.3 KB)
November 29, 2023HealthcareIR
Notice Concerning a Decision on the Licensing Agreement related to the Three Hormone Therapy Drugs for Rare Endocrine Diseases[Teijin] (PDF: 163.8 KB)
November 8, 2023IR
Notice Regarding Dividends Received from Consolidated Subsidiaries[Teijin] (PDF: 83.4 KB)
November 6, 2023IR
Consolidated Financial Statements Summary (For the six months ended September 30, 2023)[Teijin]
November 6, 2023IR
Flash Report -Results of FY2023 2Q & Outlook for FY2023-[Teijin]
October 5, 2023IR
Teijin posts Integrated Report 2023[Teijin]
August 7, 2023IR
Consolidated Financial Statements Summary (For the three months ended June 30, 2023)[Teijin]
August 7, 2023IR
Flash Report -Results of FY2023 1Q & Outlook for FY2023-[Teijin]
August 7, 2023IR
Notice on Change in a Consolidated Subsidiary (Share Transfer)[Teijin] (PDF: 185.8 KB)
July 27, 2023IR
Notice Regarding Dividend Received from a Consolidated Subsidiary[Teijin] (PDF: 71.9 KB)
July 19, 2023IR
Notice Concerning Completion of Payment for the Disposal of Treasury Shares as “Restricted Stock”[Teijin] (PDF: 116.3 KB)
June 21, 2023IR
Notice Concerning the Disposal of Treasury Shares as “Restricted Stock”[Teijin] (PDF: 134.8 KB)
May 31, 2023IR
Notice on Establishment of a Subsidiary by Company Split (Simplified Incorporation-type Company Split)[Teijin] (PDF: 149.9 KB)
May 11, 2023IR
Consolidated Financial Statements Summary (For the year ended March 31, 2023)[Teijin]
May 11, 2023IR
Flash Report -Results of FY2022 & Outlook for FY2023-[Teijin]
May 11, 2023IR
Notice Regarding Voluntary Adoption of International Financial Reporting Standards (IFRS)[Teijin] (PDF: 83.0 KB)
March 27, 2023IR
Notice Regarding Dividends Received from Consolidated Subsidiaries[Teijin] (PDF: 73.2 KB)
March 10, 2023IR
Notice Regarding Dividend Received from a Consolidated Subsidiary[Teijin] (PDF: 71.7 KB)
February 8, 2023CorporateIR
The Teijin Group Reforms for Profitability Improvement[Teijin] (PDF: 1.5 MB)
February 8, 2023IR
Consolidated Financial Statements Summary (For the nine months ended December 31, 2022)[Teijin]
February 8, 2023IR
Flash Report -Results of FY2022 3Q & Outlook for FY2022-[Teijin]
February 8, 2023IR
Notice Regarding the Revision of Financial Forecasts and the Recording of Extraordinary Losses in Consolidated and Non-consolidated Accounts[Teijin] (PDF: 97.4 KB)
February 3, 2023IR
Notice Regarding Change in Representative Directors[Teijin] (PDF: 131.6 KB)
November 7, 2022IR
Consolidated Financial Statements Summary (For the six months ended September 30, 2022)[Teijin]
November 7, 2022IR
Flash Report -Results of FY2022 2Q & Outlook for FY2022-[Teijin]
November 7, 2022IR
Notice Regarding the Revision of Financial Forecasts and the Dividend Forecast[Teijin] (PDF: 116.6 KB)
October 3, 2022IR
Teijin posts Integrated Report 2022[Teijin]
August 8, 2022IR
Consolidated Financial Statements Summary (For the three months ended June 30, 2022)[Teijin]
August 8, 2022IR
Flash Report -Results of FY2022 1Q & Outlook for FY2022-[Teijin]
July 20, 2022IR
Notice Concerning Completion of Payment for the Disposal of Treasury Shares as “Restricted Stock”[Teijin] (PDF: 122.6 KB)
June 22, 2022IR
Notice Concerning the Disposal of Treasury Shares as “Restricted Stock”[Teijin] (PDF: 139.9 KB)
May 12, 2022IR
Consolidated Financial Statements Summary (For the year ended March 31, 2022)[Teijin]
May 12, 2022IR
Flash Report -Results of FY2021 & Outlook for FY2022-[Teijin]
April 28, 2022IR
Notice Regarding the Recording of Extraordinary Income in Non-consolidated Accounts[Teijin] (PDF: 72.2 KB)
March 25, 2022IR
Teijin Held ESG Briefing Session[Teijin]
February 7, 2022IR
Consolidated Financial Statements Summary (For the nine months ended December 31, 2021)[Teijin]
February 7, 2022IR
Flash Report -Results of FY2021 3Q & Outlook for FY2021-[Teijin]
December 27, 2021IR
Teijin Held Regenerative Medicine Business Presentation[Teijin]
December 23, 2021IR
Notice Regarding Change in Representative Directors[Teijin] (PDF: 278.6 KB)
November 30, 2021IR
Notice of Application for Selection of Prime Market in Tokyo Stock Exchange New Market Segments[Teijin] (PDF: 108.1 KB)
November 8, 2021IR
Consolidated Financial Statements Summary (For the six months ended September 30, 2021)[Teijin]
November 8, 2021IR
Flash Report -Results of FY2021 2Q & Outlook for FY2021-[Teijin]
November 8, 2021IR
Notice Regarding Dividends from Surplus (Interim Dividends)[Teijin] (PDF: 82.8 KB)
November 8, 2021IR
Notice Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2021[Teijin] (PDF: 143.2 KB)
September 22, 2021IR
Notice Regarding Change of Trade Names of Overseas Consolidated Subsidiaries[Teijin] (PDF: 77.3 KB)
September 15, 2021IR
Teijin posts Integrated Report 2021[Teijin]
August 6, 2021IR
Consolidated Financial Statements Summary (For the three months ended June 30, 2021)[Teijin]
August 6, 2021IR
Flash Report -Results of FY2021 1Q & Outlook for FY2021-[Teijin]
August 4, 2021IR
Notice Concerning Completion of Payment for the Disposal of Treasury Shares as “Restricted Stock”[Teijin] (PDF: 124.8 KB)
July 15, 2021IR
Notice Regarding Pricing of Hybrid Bonds (Subordinated Bonds)[Teijin] (PDF: 93.7 KB)
July 13, 2021IR
Notice Concerning the Disposal of Treasury Shares as “Restricted Stock”[Teijin] (PDF: 132.6 KB)
June 21, 2021IR
Notice Regarding Public Offering of Hybrid Bonds (Subordinated Bonds)[Teijin] (PDF: 91.5 KB)
June 8, 2021IR
Teijin Held Business Overview Presentation[Teijin]
May 11, 2021IR
Notice Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2021[Teijin] (PDF: 91.6 KB)
May 11, 2021IR
Notice Concerning Revision of Amount of Remuneration, etc. and Introduction of “Restricted Stock” and “Performance Share Units” as Remuneration Plan for Directors of the Company[Teijin] (PDF: 133.6 KB)
May 11, 2021IR
Consolidated Financial Statements Summary (For the year ended March 31, 2021)[Teijin]
May 11, 2021IR
Flash Report -Results of FY2020 & Outlook for FY2021-[Teijin]
April 28, 2021IR
Notice Regarding the Revision of Financial Forecasts and the Recording of Extraordinary Losses in Consolidated and Non-consolidated Accounts[Teijin] (PDF: 94.4 KB)
April 20, 2021IR
Teijin Held Healthcare Business Field Presentation[Teijin]
April 1, 2021HealthcareIR
Notice Regarding Completion of Transfer of Japan Sales of Type 2 Diabetes Treatments[Teijin] (PDF: 82.4 KB)
March 15, 2021IR
Notice Regarding Determination of the Issue Price for Stock Acquisition Rights as Stock Options[Teijin] (PDF: 140.5 KB)
March 3, 2021IR
Notice Regarding Result of Tender Offer for Shares in Japan Tissue Engineering Co., Ltd. (Stock Code: 7774)[Teijin] (PDF: 155.9 KB)
February 26, 2021HealthcareIR
Notice Regarding Execution of Asset Transfer Agreement for Transfer of Japan Sales, Intellectual Properties, and Manufacturing and Marketing Approval of Type 2 Diabetes Treatments (Nesina®, Liovel®, Inisync®, and Zafatek®)[Teijin] (PDF: 206.4 KB)
February 26, 2021IR
Notice Regarding the Issuance of Stock Acquisition Rights as Stock Options[Teijin] (PDF: 256.6 KB)
February 8, 2021IR
Consolidated Financial Statements Summary (For the nine months ended December 31, 2020)[Teijin]
February 8, 2021IR
Flash Report -Results of FY2020 3Q & Outlook for FY2020-[Teijin]
February 8, 2021IR
Notice Regarding the Revision of Financial Forecasts[Teijin] (PDF: 106.0 KB)
February 3, 2021IR
Notice Regarding Change in Representative Directors[Teijin] (PDF: 148.6 KB)
January 29, 2021IR
Notice Regarding Commencement of Tender Offer for Shares in, and Execution of Capital and Business Alliance Agreement with, Japan Tissue Engineering Co., Ltd. (Stock Code: 7774)[Teijin] (PDF: 204.1 KB)
December 15, 2020IR
Announcement regarding Change of Status of an Equity Method Affiliate to Consolidated Subsidiary[Teijin] (PDF: 201.6 KB)
November 2, 2020IR
Consolidated Financial Statements Summary (For the six months ended September 30, 2020)[Teijin]
November 2, 2020IR
Flash Report -Results of FY2020 2Q & Outlook for FY2020-[Teijin]
November 2, 2020IR
Notice Regarding the Revision of Financial Forecasts[Teijin] (PDF: 70.8 KB)
November 2, 2020IR
Notice Regarding Dividends from Surplus (Interim Dividends) and Year-end Dividend Forecast[Teijin] (PDF: 157.7 KB)
November 2, 2020IR
Notice Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2021[Teijin] (PDF: 143.4 KB)
October 15, 2020IR
Teijin Held Materials Business Field Presentation[Teijin]
September 24, 2020IR
Teijin posts Integrated Report 2020[Teijin]
August 5, 2020IR
Consolidated Financial Statements Summary (For the three months ended June 30, 2020)[Teijin]
August 5, 2020IR
Flash Report -Results of FY2020 1Q & Outlook for FY2020-[Teijin]
August 5, 2020IR
Notice Regarding the Revision of Financial Forecasts[Teijin] (PDF: 79.1 KB)
August 5, 2020IR
(Notice) Regarding partial revisions of business results presentation materials for past fiscal years[Teijin] (PDF: 592.6 KB)
May 8, 2020IR
Consolidated Financial Statements Summary (For the year ended March 31, 2020)[Teijin]
May 8, 2020IR
Flash Report -Results of FY2019 & Outlook for FY2020-[Teijin]
May 8, 2020IR
Notice Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2021[Teijin] (PDF: 94.1 KB)
March 16, 2020IR
Notice Regarding Determination of the Issue Price for Stock Acquisition Rights as Stock Options[Teijin] (PDF: 142.5 KB)
February 28, 2020IR
Notice Regarding the Issuance of Stock Acquisition Rights as Stock Options[Teijin] (PDF: 252.8 KB)
February 5, 2020IR
Consolidated Financial Statements Summary (For the nine months ended December 31, 2019) [Teijin]
February 5, 2020IR
Flash Report -Results of FY2019 3Q & Outlook for FY2019-[Teijin]
February 5, 2020IR
Medium-Term Management Plan 2020–2022 “ALWAYS EVOLVING”[Teijin]
January 31, 2020IR